Position in XENE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$12,099,222
+$1,569,130 QoQ
Shares Held
200,451
+10.7% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#80
of 313 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DNB Asset Management AS holds $308,807,747 across 74 Biotechnology names. XENE ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
1,268,194 | $72,566,060 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,106 | $53,699,493 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
49,314 | $30,749,251 | |
| 4 | INSM |
INSMED Inc
|
213,259 | $22,737,674 | |
| 5 | INCY |
Incyte Corp
|
161,470 | $18,304,239 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
54,076 | $16,278,498 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
65,199 | $15,958,759 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
200,451 | $12,099,222 |
All Filings in XENE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,099,222 | 200,451 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $10,530,092 | 181,085 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $12,228,285 | 272,831 | Shares | Other | 2026-02-05 | |
| 2025-09-30 | $10,000,602 | 249,081 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $7,329,114 | 234,157 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $7,699,121 | 229,482 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $7,967,125 | 203,243 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $7,504,827 | 190,623 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $6,851,829 | 175,733 | Shares | Other | 2024-07-05 | |
| 2024-03-31 | $5,435,062 | 126,250 | Shares | Other | 2024-04-12 | |
| 2023-12-31 | $5,820,832 | 126,375 | Shares | Other | 2024-01-04 | |
| 2023-09-30 | $4,159,663 | 121,770 | Shares | Other | 2023-10-13 | |
| 2023-06-30 | $4,336,216 | 112,629 | Shares | Other | 2023-07-10 | |
| 2023-03-31 | $3,538,163 | 98,859 | Shares | Other | 2023-04-20 | |
| 2022-12-31 | $3,728,145 | 94,551 | Shares | Other | 2023-01-12 | |
| No filing history on record for this holder in this stock. | ||||||